Aurora Innovation, Inc. AUR
4.27 USD +0.04 (+0.95%)
At closeNov 3, 2026, 4:14 PM EST
4.29 +0.02 +0.47%
After hours · Nov 3, 4:14 PM ET
4.17 Day range 4.44
3.60 52-week range 8.57
- YTD
- +11.20%
- 1 year
- -15.45%
Analyst view
Consensus: buy
Buy
Price target (mean) 11.55 +170.5% upside
Now 4.27
- Target (low)
- 3.59
- Target (mean)
- 11.55
- Target (high)
- 18.00
Ratings (0m) 13 8 buy · 5 hold · 0 sell
- Strong buy2
- Buy6
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.125 | -0.14 – -0.12 | -0.11 | -13.6% | 3.16M | +216.1% | 10 |
| Next quarter | -0.12833 | -0.14 – -0.12 | -0.11 | -16.7% | 12.29M | +1128.9% | 6 |
| Current year | -0.46 | -0.46 – -0.46 | -0.3415 | -34.7% | 9.12M | +203.8% | 1 |
| Next year | -0.47 | -0.47 – -0.47 | -0.46 | -2.2% | 150.00M | +1545.7% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Oct 29, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Oct 29, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Oct 29, 2026 | Needham | Maintained | Buy | Buy |
| Oct 8, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 25, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Sep 24, 2026 | Amerx | Reiterated | Hold | Hold |
| Sep 24, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Sep 24, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 24, 2026 | Needham | Reiterated | Buy | Buy |
| Sep 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 23, 2026 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 5, 2026 | Craig-Hallum | Initiated | — | Buy |
| May 29, 2026 | Northland Capital Markets | Initiated | — | Outperform |
| May 11, 2026 | Amerx | Initiated | — | Hold |
| May 7, 2026 | TD Cowen | Maintained | Hold | Hold |
| May 7, 2026 | Needham | Reiterated | Buy | Buy |
| Apr 17, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Feb 13, 2026 | TD Cowen | Maintained | Hold | Hold |
| Feb 12, 2026 | Needham | Reiterated | Buy | Buy |
| Nov 26, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| Oct 30, 2025 | TD Cowen | Maintained | Hold | Hold |
| Oct 29, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| May 12, 2025 | Goldman Sachs | Maintained | Neutral | Neutral |
| May 9, 2025 | Needham | Maintained | Buy | Buy |
| May 2, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 15, 2025 | Needham | Initiated | — | Buy |
| Apr 10, 2025 | Goldman Sachs | Upgrade | Sell | Neutral |
| Mar 27, 2025 | Oppenheimer | Initiated | — | Outperform |
| Mar 3, 2025 | Morgan Stanley | Initiated | — | Overweight |